October 16, 2024 17:00 Non Regulatory Flerie AB’s Nomination Committee for the 2025 Annual General Meeting
October 11, 2024 08:00 Non Regulatory Invitation to presentation and Q&A of Flerie’s Q3 2024 interim report
October 11, 2024 08:00 Non Regulatory Inbjudan till presentation och frågestund avseende Fleries delårsrapport Q3 2024
July 29, 2024 12:42 Non Regulatory Flerie increases its shareholding in Xspray Pharma and comments on FDA feedback on Dasynoc
July 29, 2024 12:42 Non Regulatory Flerie ökar sitt ägande i Xspray Pharma och kommenterar FDA-svar angående Dasynoc
July 12, 2024 08:00 Non Regulatory Invitation to presentation and Q&A of Flerie’s Q2 2024 interim report
July 12, 2024 08:00 Non Regulatory Inbjudan till presentation och Q&A av Fleries delårsrapport Q2 2024
March 6, 2024 Flerie Invest AB lämnar ett kontant budpliktsbud till aktieägarna och konvertibelinnehavaren i Lipum AB (publ) samt offentliggör erbjudandehandling
March 1, 2024 Flerie Invest AB har ökat sitt innehav i Lipum AB (publ) varigenom gränsen för budplikt passerats
March 1, 2024 Flerie Invest AB has increased its holding in Lipum AB (publ), whereby the limit for mandatory bidding has been exceeded